Literature DB >> 17083499

Health-related quality of life in veterans and nonveterans with HIV/AIDS.

Joseph M Mrus1, Anthony C Leonard, Michael S Yi, Susan N Sherman, Shawn L Fultz, Amy C Justice, Joel Tsevat.   

Abstract

PURPOSE: To compare health-related quality of life (HRQoL) between patients receiving care in Veterans Administration (VA) settings (veterans) and non-VA settings (nonveterans), and to explore determinants of HRQoL and change in HRQoL over time in subjects living with HIV/AIDS.
SUBJECTS: One hundred veterans and 350 nonveterans with HIV/AIDS from 2 VA and 2 university-based sites in 3 cities interviewed in 2002 to 2003 and again 12 to 18 months later.
METHODS: We assessed health status (functional status and symptom bother), health ratings, and health values (time tradeoff [TTO] and standard gamble [SG] utilities). We also explored bivariate and multivariable associations of HRQoL measures with a number of demographic, clinical, spiritual/religious, and psychosocial characteristics.
RESULTS: Compared with nonveterans, the veteran population was older (47.7 vs 42.0 years) and consisted of a higher proportion of males (97% vs 83%), of participants with a history of injection drug use (23% vs 15%), and of subjects with unstable housing situations (14% vs 6%; P<.05 for all comparisons). On scales ranging from 0 (worst) to 100 (best), veterans reported significantly poorer overall function (mean [SD]; 65.9 [17.2] vs 71.9 [16.8]); lower rating scale scores (67.6 [21.7] vs 73.5 [21.0]), lower TTO values (75.7 [37.4] vs 89.0 [23.2]), and lower SG values (75.0 [35.8] vs 83.2 [28.3]) than nonveterans (P<.05 for all comparisons); however, in multivariable models, veteran status was only a significant determinant of SG and TTO values at baseline. Among other determinants that were associated with multiple HRQoL outcomes in baseline and follow-up multivariable analyses were: symptom bother, overall function, religiosity/spirituality, depressive symptoms, and financial worries.
CONCLUSIONS: Veterans reported significantly poorer HRQoL than nonveterans, but when controlling for other factors, veteran status was only a significant determinant of TTO and SG health values at baseline. Correlates of HRQoL such as symptom bother, spirituality/religiosity, and depressive symptoms could be fruitful potential targets for interventions to improve HRQoL in patients with HIV/AIDS.

Entities:  

Mesh:

Year:  2006        PMID: 17083499      PMCID: PMC1924783          DOI: 10.1111/j.1525-1497.2006.00644.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  43 in total

1.  What should be reported in a methods section on utility assessment?

Authors:  P F Stalmeier; M K Goldstein; A M Holmes; L Lenert; J Miyamoto; A M Stiggelbout; G W Torrance; J Tsevat
Journal:  Med Decis Making       Date:  2001 May-Jun       Impact factor: 2.583

2.  Lipodystrophy associated with nevirapine-containing antiretroviral therapies.

Authors:  T Aldeen; C Wells; P Hay; F Davidson; R Lau
Journal:  AIDS       Date:  1999-05-07       Impact factor: 4.177

3.  Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one?

Authors:  Joseph M Mrus; Kenneth E Sherman; Anthony C Leonard; Susan N Sherman; Karen L Mandell; Joel Tsevat
Journal:  Med Care       Date:  2006-02       Impact factor: 2.983

4.  The effect of diagnosis with HIV infection on health-related quality of Life.

Authors:  Shyoko Honiden; Vandana Sundaram; Robert F Nease; Mark Holodniy; Laura C Lazzeroni; Andrew Zolopa; Douglas K Owens
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

5.  Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group.

Authors:  A C Justice; L Rabeneck; R D Hays; A W Wu; S A Bozzette
Journal:  J Acquir Immune Defic Syndr       Date:  1999-06-01       Impact factor: 3.731

6.  The will to live among HIV-infected patients.

Authors:  J Tsevat; S N Sherman; J A McElwee; K L Mandell; L A Simbartl; F A Sonnenberg; F J Fowler
Journal:  Ann Intern Med       Date:  1999-08-03       Impact factor: 25.391

7.  The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans.

Authors:  Kristina Crothers; Tephany A Griffith; Kathleen A McGinnis; Maria C Rodriguez-Barradas; David A Leaf; Sharon Weissman; Cynthia L Gibert; Adeel A Butt; Amy C Justice
Journal:  J Gen Intern Med       Date:  2005-12       Impact factor: 5.128

8.  Gender differences in health-related quality of life in patients with HIV/AIDS.

Authors:  Joseph M Mrus; Paige L Williams; Joel Tsevat; Susan E Cohn; Albert W Wu
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

9.  Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection.

Authors:  K A Lorenz; M F Shapiro; S M Asch; S A Bozzette; R D Hays
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

10.  Predictors of changes in health-related quality of life among men with HIV infection in the HAART era.

Authors:  Huanguang Jia; Constance R Uphold; Samuel Wu; G John Chen; Pamela W Duncan
Journal:  AIDS Patient Care STDS       Date:  2005-06       Impact factor: 5.078

View more
  24 in total

1.  The importance of spirituality/religion and health-related quality of life among individuals with HIV/AIDS.

Authors:  Hayden B Bosworth
Journal:  J Gen Intern Med       Date:  2006-12       Impact factor: 5.128

2.  Thirty down, only ten to go?! Awareness and influence of a 10-year time frame in TTO.

Authors:  F E van Nooten; X Koolman; J J V Busschbach; W B F Brouwer
Journal:  Qual Life Res       Date:  2013-08-14       Impact factor: 4.147

3.  Health-related quality of life and comorbidity among older women veterans in the United States.

Authors:  Claudia Der-Martirosian; Kristina M Cordasco; Donna L Washington
Journal:  Qual Life Res       Date:  2013-05-08       Impact factor: 4.147

4.  Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir.

Authors:  E Jennifer Edelman; Kirsha Gordon; Maria C Rodriguez-Barradas; Amy C Justice
Journal:  AIDS Patient Care STDS       Date:  2012-05-21       Impact factor: 5.078

5.  Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics.

Authors:  P Todd Korthuis; Mary Jo Tozzi; Vijay Nandi; David A Fiellin; Linda Weiss; James E Egan; Michael Botsko; Angela Acosta; Marc N Gourevitch; David Hersh; Jeffrey Hsu; Joshua Boverman; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

6.  Multidimensional assessment of spirituality/religion in patients with HIV: conceptual framework and empirical refinement.

Authors:  Magdalena Szaflarski; Ian Kudel; Sian Cotton; Anthony C Leonard; Joel Tsevat; P Neal Ritchey
Journal:  J Relig Health       Date:  2012-12

7.  Health-related quality of life in bereaved HIV-positive adults: relationships between HIV symptoms, grief, social support, and Axis II indication.

Authors:  Nathan B Hansen; Ellen L Vaughan; Courtenay E Cavanaugh; Christian M Connell; Kathleen J Sikkema
Journal:  Health Psychol       Date:  2009-03       Impact factor: 4.267

8.  Treatment decisions for complex patients: differences between primary care physicians and midlevel providers.

Authors:  Usha Subramanian; Eve A Kerr; Mandi L Klamerus; Brian J Zikmund-Fisher; Robert G Holleman; Timothy P Hofer
Journal:  Am J Manag Care       Date:  2009-06       Impact factor: 2.229

9.  Measurement invariance of the kidney disease and quality of life instrument (KDQOL-SF) across veterans and non-veterans.

Authors:  Karen L Saban; Fred B Bryant; Domenic J Reda; Kevin T Stroupe; Denise M Hynes
Journal:  Health Qual Life Outcomes       Date:  2010-10-25       Impact factor: 3.186

10.  Factors influencing quality of life of people living with HIV in Estonia: a cross-sectional survey.

Authors:  Kristi Rüütel; Heti Pisarev; Helle-Mai Loit; Anneli Uusküla
Journal:  J Int AIDS Soc       Date:  2009-07-16       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.